|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/39 |
| (11) | Patento numeris | 3151856 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15722448.6 |
| Europos patento paraiškos padavimo data | 2015-05-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/000974 |
| Data | 2015-05-12 |
| (87) | Numeris | WO 2015/185180 |
| Data | 2015-12-10 |
| (30) | Numeris | Data | Šalis |
| 14001974 | 2014-06-06 | EP |
| (72) |
HANEFELD, Andrea, DE
WEIGANDT, Markus, DE
WOLF, Michael, DE
KNOLLE, Percy, DE
SCHROEDER, Matthias, DE
SCHERLIESS, Regina, DE
WALDEN, Peter, DE
DIEDRICH, Andrea, DE
STECKEL, Hartwig, DE
BALEEIRO, Renato Brito, GB
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | ANTIGEN-LOADED CHITOSAN NANOPARTICLES FOR IMMUNOTHERAPY |
| ANTIGEN-LOADED CHITOSAN NANOPARTICLES FOR IMMUNOTHERAPY |